FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810368050> ?p ?o ?g. }

• W2810368050 endingPage "469" @default.
• W2810368050 startingPage "464" @default.
• W2810368050 abstract "We aim to describe the efficacy, safety profile, and variables associated with survival in patients with hepatocellular carcinoma (HCC) treated with sorafenib in South America.Sorafenib has been shown to improve survival in patients with advanced HCC. There are few data on sorafenib use for HCC in South America.We performed a retrospective analysis of HCC cases treated with sorafenib from 8 medical centers in 5 South American countries, between January 2010 and June 2017. The primary endpoint was overall survival (OS), which was defined as time from sorafenib initiation to death or last follow-up. Risk factors for decreased OS were assessed using Cox proportional hazard regression and log-rank tests.Of 1336 evaluated patients, 127 were treated with sorafenib and were included in the study. The median age of individuals was 65 years (interquartile range, 55 to 71) and 70% were male individuals. Median OS in all patients was 8 months (interquartile range, 2 to 17). Variables associated with survival on multivariate analysis were platelets >/<250,000 mm (2 vs. 8 mo, P=0.01) and Barcelona Clinic Liver Cancer (BCLC) stage (A/B, 13 vs. C/D, 6 mo; P=0.04). In a subanalysis of patients with BCLC stage C, platelets >/<250,000 mm were also independently associated with survival (2 vs. 5.5 mo, P=0.03). Patients lived longer if they experienced any side effects from sorafenib use (11 vs. 2 mo, P=0.009). Patients who stopped sorafenib because of side effects had shorter survival compared with patients who were able to tolerate side effects and continue treatment (7.5 vs. 13 mo, P=0.01).Pretreatment elevation of platelets and advanced BCLC stage were independently associated with poor survival on sorafenib in a South American cohort." @default.
• W2810368050 created "2018-07-10" @default.
• W2810368050 creator A5006990201 @default.
• W2810368050 creator A5011225988 @default.
• W2810368050 creator A5016341754 @default.
• W2810368050 creator A5017627721 @default.
• W2810368050 creator A5028193804 @default.
• W2810368050 creator A5035985168 @default.
• W2810368050 creator A5036744682 @default.
• W2810368050 creator A5038206936 @default.
• W2810368050 creator A5059454779 @default.
• W2810368050 creator A5067940252 @default.
• W2810368050 creator A5071946418 @default.
• W2810368050 creator A5072744089 @default.
• W2810368050 creator A5075172051 @default.
• W2810368050 date "2019-07-01" @default.
• W2810368050 modified "2023-10-18" @default.
• W2810368050 title "Sorafenib for Treatment of Hepatocellular Carcinoma" @default.
• W2810368050 cites W1757407923 @default.
• W2810368050 cites W1971837077 @default.
• W2810368050 cites W1973659646 @default.
• W2810368050 cites W1978612707 @default.
• W2810368050 cites W1982768990 @default.
• W2810368050 cites W1983217803 @default.
• W2810368050 cites W1989647054 @default.
• W2810368050 cites W1994193851 @default.
• W2810368050 cites W1994426116 @default.
• W2810368050 cites W2013804937 @default.
• W2810368050 cites W2024745652 @default.
• W2810368050 cites W2028319026 @default.
• W2810368050 cites W2046000826 @default.
• W2810368050 cites W2058887247 @default.
• W2810368050 cites W2060123467 @default.
• W2810368050 cites W2066954468 @default.
• W2810368050 cites W2138424758 @default.
• W2810368050 cites W2158207366 @default.
• W2810368050 cites W2164984825 @default.
• W2810368050 cites W2411616513 @default.
• W2810368050 cites W2502891277 @default.
• W2810368050 cites W2580579569 @default.
• W2810368050 cites W2590775279 @default.
• W2810368050 cites W2590908536 @default.
• W2810368050 cites W2595970240 @default.
• W2810368050 cites W2615190480 @default.
• W2810368050 cites W2625559053 @default.
• W2810368050 cites W2662694807 @default.
• W2810368050 cites W2727497670 @default.
• W2810368050 cites W2741672967 @default.
• W2810368050 cites W2763970096 @default.
• W2810368050 cites W2765110984 @default.
• W2810368050 cites W2779747165 @default.
• W2810368050 cites W4211105405 @default.
• W2810368050 doi "https://doi.org/10.1097/mcg.0000000000001085" @default.
• W2810368050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29952857" @default.
• W2810368050 hasPublicationYear "2019" @default.
• W2810368050 type Work @default.
• W2810368050 sameAs 2810368050 @default.
• W2810368050 citedByCount "20" @default.
• W2810368050 countsByYear W28103680502018 @default.
• W2810368050 countsByYear W28103680502019 @default.
• W2810368050 countsByYear W28103680502020 @default.
• W2810368050 countsByYear W28103680502021 @default.
• W2810368050 countsByYear W28103680502022 @default.
• W2810368050 countsByYear W28103680502023 @default.
• W2810368050 crossrefType "journal-article" @default.
• W2810368050 hasAuthorship W2810368050A5006990201 @default.
• W2810368050 hasAuthorship W2810368050A5011225988 @default.
• W2810368050 hasAuthorship W2810368050A5016341754 @default.
• W2810368050 hasAuthorship W2810368050A5017627721 @default.
• W2810368050 hasAuthorship W2810368050A5028193804 @default.
• W2810368050 hasAuthorship W2810368050A5035985168 @default.
• W2810368050 hasAuthorship W2810368050A5036744682 @default.
• W2810368050 hasAuthorship W2810368050A5038206936 @default.
• W2810368050 hasAuthorship W2810368050A5059454779 @default.
• W2810368050 hasAuthorship W2810368050A5067940252 @default.
• W2810368050 hasAuthorship W2810368050A5071946418 @default.
• W2810368050 hasAuthorship W2810368050A5072744089 @default.
• W2810368050 hasAuthorship W2810368050A5075172051 @default.
• W2810368050 hasConcept C119060515 @default.
• W2810368050 hasConcept C126322002 @default.
• W2810368050 hasConcept C141071460 @default.
• W2810368050 hasConcept C143998085 @default.
• W2810368050 hasConcept C167135981 @default.
• W2810368050 hasConcept C207103383 @default.
• W2810368050 hasConcept C2776231280 @default.
• W2810368050 hasConcept C2778019345 @default.
• W2810368050 hasConcept C2778695046 @default.
• W2810368050 hasConcept C44249647 @default.
• W2810368050 hasConcept C50382708 @default.
• W2810368050 hasConcept C71924100 @default.
• W2810368050 hasConcept C90924648 @default.
• W2810368050 hasConceptScore W2810368050C119060515 @default.
• W2810368050 hasConceptScore W2810368050C126322002 @default.
• W2810368050 hasConceptScore W2810368050C141071460 @default.
• W2810368050 hasConceptScore W2810368050C143998085 @default.
• W2810368050 hasConceptScore W2810368050C167135981 @default.
• W2810368050 hasConceptScore W2810368050C207103383 @default.
• W2810368050 hasConceptScore W2810368050C2776231280 @default.

• next